Crescita Therapeutics Stock Profit Margin
| CRRTF Stock | USD 0.45 0.00 0.00% |
Crescita Therapeutics fundamentals help investors to digest information that contributes to Crescita Therapeutics' financial success or failures. It also enables traders to predict the movement of Crescita Pink Sheet. The fundamental analysis module provides a way to measure Crescita Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Crescita Therapeutics pink sheet.
Crescita |
Crescita Therapeutics Company Profit Margin Analysis
Crescita Therapeutics' Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Crescita Therapeutics Profit Margin | 0.03 % |
Most of Crescita Therapeutics' fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Crescita Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Crescita Therapeutics has a Profit Margin of 0.025%. This is 100.22% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The profit margin for all United States stocks is 101.97% lower than that of the firm.
Did you try this?
Run My Watchlist Analysis Now
My Watchlist AnalysisAnalyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
| All Next | Launch Module |
Crescita Fundamentals
| Return On Equity | 0.0318 | |||
| Return On Asset | 0.0227 | |||
| Profit Margin | 0.03 % | |||
| Operating Margin | 0.04 % | |||
| Current Valuation | 3.64 M | |||
| Shares Outstanding | 20.4 M | |||
| Shares Owned By Insiders | 7.30 % | |||
| Price To Earning | 490.00 X | |||
| Price To Book | 0.66 X | |||
| Price To Sales | 0.41 X | |||
| Revenue | 16.77 M | |||
| Gross Profit | 10.01 M | |||
| EBITDA | 606 K | |||
| Net Income | (1.1 M) | |||
| Cash And Equivalents | 10.5 M | |||
| Cash Per Share | 0.51 X | |||
| Total Debt | 1.71 M | |||
| Debt To Equity | 0.09 % | |||
| Current Ratio | 3.10 X | |||
| Book Value Per Share | 0.97 X | |||
| Cash Flow From Operations | (1.6 M) | |||
| Earnings Per Share | 0.02 X | |||
| Beta | 2.08 | |||
| Market Capitalization | 11.42 M | |||
| Total Asset | 28.92 M | |||
| Z Score | 3.6 | |||
| Net Asset | 28.92 M |
About Crescita Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Crescita Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Crescita Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Crescita Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Crescita Pink Sheet
Crescita Therapeutics financial ratios help investors to determine whether Crescita Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Crescita with respect to the benefits of owning Crescita Therapeutics security.